Flossbach Von Storch’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$960M Sell
1,954,070
-224,831
-10% -$122M 4.48% 6
2025
Q4
$1.26B Sell
2,178,901
-337,197
-13% -$191M 5% 5
2025
Q3
$1.22B Sell
2,516,098
-210,923
-8% -$98.2M 4.81% 5
2025
Q2
$1.11B Buy
2,727,021
+1,314,182
+93% +$549M 4.52% 5
2025
Q1
$703M Buy
1,412,839
+77,554
+6% +$42M 3.04% 15
2024
Q4
$695M Buy
1,335,285
+7,140
+0.5% +$3.93M 2.76% 15
2024
Q3
$822M Buy
1,328,145
+6,157
+0.5% +$3.64M 3.22% 11
2024
Q2
$731M Sell
1,321,988
-17,323
-1% -$9.92M 3.06% 16
2024
Q1
$778M Sell
1,339,311
-15,431
-1% -$8.66M 3.39% 15
2023
Q4
$719M Buy
1,354,742
+90,396
+7% +$43.8M 3.28% 13
2023
Q3
$640M Buy
1,264,346
+256,043
+25% +$136M 2.82% 14
2023
Q2
$526M Buy
1,008,303
+77,937
+8% +$42.1M 2.12% 20
2023
Q1
$536M Sell
930,366
-225,320
-19% -$127M 2.26% 20
2022
Q4
$636M Buy
1,155,686
+2,354
+0.2% +$1.25M 2.43% 20
2022
Q3
$585M Buy
1,153,332
+26,682
+2% +$14.9M 2.15% 22
2022
Q2
$612M Buy
1,126,650
+164,125
+17% +$90.3M 2.05% 23
2022
Q1
$569M Buy
962,525
+156,994
+19% +$90.2M 1.59% 27
2021
Q4
$537M Buy
805,531
+6,973
+0.9% +$4.35M 1.45% 28
2021
Q3
$456M Buy
798,558
+1,885
+0.2% +$1.03M 1.33% 27
2021
Q2
$402M Buy
796,673
+451,134
+131% +$213M 1.2% 29
2021
Q1
$158M Buy
345,539
+234,508
+211% +$112M 0.56% 34
2020
Q4
$51.7M Sell
111,031
-45,902
-29% -$21.5M 0.21% 44
2020
Q3
$69.3M Sell
156,933
-11,098
-7% -$4.59M 0.34% 41
2020
Q2
$60.9M Buy
168,031
+988
+0.6% +$331K 0.32% 38
2020
Q1
$47.4M Buy
167,043
+77,735
+87% +$24.5M 0.32% 36
2019
Q4
$29M Buy
89,308
+22,900
+34% +$6.94M 0.2% 45
2019
Q3
$19.3M Buy
66,408
+44,620
+205% +$12.8M 0.15% 47
2019
Q2
$6.4M Buy
21,788
+205
+0.9% +$56.5K 0.05% 66
2019
Q1
$5.91M Sell
21,583
-265
-1% -$65.9K 0.05% 68
2018
Q4
$4.89M Buy
21,848
+240
+1% +$56.3K 0.05% 73
2018
Q3
$5.27M Sell
21,608
-15,402
-42% -$3.54M 0.05% 70
2018
Q2
$7.67M Buy
37,010
+850
+2% +$180K 0.08% 63
2018
Q1
$7.47M Sell
36,160
-3,900
-10% -$819K 0.08% 65
2017
Q4
$7.61M Sell
40,060
-2,950
-7% -$565K 0.07% 63
2017
Q3
$8.14M Sell
43,010
-3,150
-7% -$570K 0.08% 58
2017
Q2
$8.05M Sell
46,160
-450
-1% -$75.6K 0.09% 55
2017
Q1
$7.16M Sell
46,610
-8,450
-15% -$1.29M 0.11% 52
2016
Q4
$7.77M Buy
55,060
+10,100
+22% +$1.49M 0.13% 52
2016
Q3
$7.15M Buy
44,960
+7,900
+21% +$1.22M 0.12% 50
2016
Q2
$5.48M Sell
37,060
-20,960
-36% -$3.09M 0.09% 52
2016
Q1
$8.21M Buy
58,020
+6,490
+13% +$870K 0.13% 54
2015
Q4
$7.31M Buy
51,530
+700
+1% +$93.4K 0.12% 61
2015
Q3
$6.21M Buy
50,830
+9,150
+22% +$1.19M 0.11% 61
2015
Q2
$5.41M Buy
41,680
+3,950
+10% +$515K 0.1% 64
2015
Q1
$5.07M Sell
37,730
-1,150
-3% -$148K 0.11% 62
2014
Q4
$4.87M Buy
38,880
+24,240
+166% +$2.95M 0.11% 63
2014
Q3
$1.78M Sell
14,640
-2,200
-13% -$267K 0.04% 73
2014
Q2
$1.99M Sell
16,840
-1,300
-7% -$153K 0.05% 70
2014
Q1
$2.18M Sell
18,140
-15,180
-46% -$1.8M 0.06% 58
2013
Q4
$3.71M Sell
33,320
-50,850
-60% -$5.06M 0.11% 53
2013
Q3
$7.76M Buy
84,170
+5,000
+6% +$452K 0.24% 46
2013
Q2
$6.7M Buy
+79,170
New +$6.59M 0.2% 46

Other funds holding TMO

Flossbach Von Storch's TMO Position: Q1 2026 in Review

Flossbach Von Storch reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, selling an estimated $122M and leaving 1,954,070 shares worth $960M. The position accounts for 4.48% of the portfolio, ranked #6.

Flossbach Von Storch first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.26B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Flossbach Von Storch held 1,954,070 shares of Thermo Fisher Scientific worth $960M as of Q1 2026.
  • Flossbach Von Storch sold 224,831 Thermo Fisher Scientific shares in Q1 2026, an estimated $122M.
  • Thermo Fisher Scientific made up 4.48% of Flossbach Von Storch's portfolio in Q1 2026, its #6 holding.
  • Flossbach Von Storch first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Flossbach Von Storch's Thermo Fisher Scientific position peaked at $1.26B in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Flossbach Von Storch's 13F filing for Q1 2026, filed 29 Apr 2026.